A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds

Recruiting now · Not applicable

Conditions studied: Nasolabial Folds, Wrinkles

In brief

This is a prospective clinical investigation designed to evaluate the performance and safety of DMFI150 for the treatment of nasolabial folds. 30 adult participants will receive a single treatment with the investigational device. The study will assess wrinkle severity using validated aesthetic evaluation scales, as well as overall safety.

Key facts

Study ID

NCT07292779

Run by

Samyang Biopharmaceuticals Corporation

People needed

30

Starts

2025-11-24

Expected to finish

2026-12-01

Last updated by the study team

2026-03-05

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women aged 18-70 years.
• Score of 3 to 4 on the WSRS (1 = absent, 2 = mild, 3 = moderate, 4 = severe, and 5 = extreme) for both nasolabial folds.
• Able and willing to provide written informed consent.
• Willing to refrain from facial cosmetic procedures during the study.

You may not qualify if…

• Use of antiplatelet agents, vitamin E, or NSAIDs within 2 weeks before screening or 2 weeks after treatment.
• History or current bleeding disorders.
• Participation in another clinical trial within 1 month before screening.
• Pregnant or breastfeeding women, or planning pregnancy.
• Women of childbearing potential not using effective contraception.

Where it is running

• Ocean Clinic — Marbella, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.